Cencora
Financials
Estimates*
| USD | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenues | 189.9b | 214.0b | 238.6b |
| % growth | - | 13 % | 11 % |
| EBITDA | 2.4b | 3.4b | 3.5b |
| % EBITDA margin | 1 % | 2 % | 1 % |
| Profit | (3.4b) | 1.5b | 1.7b |
| % profit margin | (2 %) | 1 % | 1 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | N/A | $500m | Post IPO Debt |
* | N/A | $500m | POST IPO SECONDARY |
* | N/A | $500m | Post IPO Debt |
| Total Funding | - | ||
Related Content
Recent News about Cencora
EditAmerisourceBergen, now operating under the name Cencora, is a leading global pharmaceutical solutions organization. The company has a rich history dating back to 1871 and has evolved into a key player in the healthcare industry. Cencora focuses on improving the lives of people and animals by advancing pharmaceutical care. The company serves a wide range of clients, including healthcare providers, pharmaceutical manufacturers, and veterinary practices.
Cencora operates in the pharmaceutical distribution and services market. It provides a comprehensive suite of services that include drug distribution, specialty pharmacy services, and consulting. The company also offers solutions for supply chain management, patient support, and data analytics. By integrating these services, Cencora helps its clients improve efficiency, reduce costs, and enhance patient outcomes.
The business model of Cencora revolves around providing value-added services to its clients. It makes money primarily through the distribution of pharmaceuticals and related products. Additionally, the company generates revenue from consulting services, data analytics, and patient support programs. By offering a broad range of services, Cencora ensures a steady stream of income from various sources within the healthcare ecosystem.
Cencora is also committed to social responsibility and sustainability. The company has invested $100 million in Project Black, a private equity fund aimed at creating minority-owned businesses that can serve as top-tier vendors to Fortune 500 companies. This initiative is part of Cencora's broader commitment to Environmental, Social, and Governance (ESG) principles, which are detailed in its annual ESG report.
In summary, Cencora is a comprehensive pharmaceutical solutions provider dedicated to improving healthcare outcomes. It serves a diverse clientele, operates in the pharmaceutical distribution market, and employs a multifaceted business model to generate revenue.
Keywords: Pharmaceutical, Distribution, Healthcare, Solutions, Consulting, Supply Chain, Patient Support, Data Analytics, ESG, Project Black.
Tech stack
